Unilever PLC
UL Details
Unilever PLC (NYSE: UL) is a multinational fast-moving consumer goods (FMCG) firm that focuses on the Beauty & Personal Care (BPC), Home Care (HC), and Foods & Refreshment (FR) areas. The BPC segment's five categories include deodorants, skin cleaning, hair care, oral care, and skincare. The Home Care segment sells laundry and household care products. In the FR section, you may find food and ice cream. Products from the company are distributed in 190 countries.
H1FY21 Results:
- Flat Topline: Turnover grew 0.30% to EUR 25.79 billion during H1FY21 (ended June 30, 2021) from EUR 25.71 billion during H1FY20.
- Decline in Bottomline: The net profit for H1FY21 was EUR 3.40 billion, compared to EUR 3.54 billion during H1FY20, for diluted earnings per share (EPS) of EUR 1.19.
- Leveraged Balance Sheet: The company's cash and cash equivalents (including short-term investments) were at EUR 5.07 billion as of June 30, 2021, with a total debt of EUR 27.54 billion.
Key Risks:
- Plastic Usage Risk: Plastic is often employed in the packaging of the company's products. However, its long-term effectiveness is dependent on reducing the amount of virgin plastic consumed, increasing the utilization of recycled plastic, and improving the recyclability of the packaging.
- Supply Chain Risk: The timely purchasing of supplies and distribution of items to customers is critical to the company's success. Unfortunately, physical disruptions, environmental and industrial disasters, trade restrictions, or challenges with a significant supplier could all impact its capacity to deliver orders to customers via the supply chain network.
Outlook:
- FY21 Guidance: According to UL, as of November 01, 2021, cost inflation is still relatively high and will continue next year. It has responded and will continue to respond by altering prices and implementing other cost-cutting strategies across its categories and markets. As a result, it anticipates meeting its FY21 margin forecast, which is likely to remain essentially flat.
Valuation Methodology: Price/Earnings Per Share Multiple Based Relative Valuation
(Analysis by Kalkine Group)
* % Premium/(Discount) is based on our assessment of the company's NTM trading multiple after considering its key growth drivers, economic moat, stock's historical trading multiples versus peer average/median, and investment risks.
UL Daily Technical Chart (Source: REFINITIV)
Stock Recommendation:
UL's share price has surged 3.01% in the past month and is currently leaning towards the lower-band of the 52-week range of USD 50.60 to USD 61.81. The stock is currently trading between its 50 and 200 DMA levels, and its RSI Index is at 60.16. We have valued the stock using the Price/Earnings-based relative valuation methodology and arrived at a target price of USD 46.42.
Considering the company's acquisition prospects, a decline in outlook, deterioration in the bottom line, current valuation, and technical indicators, we believe the decent business fundamentals are adequately reflected at current trading levels. Hence, we recommend a "Sell" rating on the stock at the closing price of USD 54.29, up 1.14%, as of January 14, 2022.
*All forecasted figures and Industry Information have been taken from REFINITIV.
*The reference data in this report has been partly sourced from REFINITIV.
Disclaimer - This report has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine.
Any advice provided in this report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your objectives, financial situation and needs before acting upon it.
There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine reports. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product.
You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice in this report or on the Kalkine website. Not all investments are appropriate for all people.
The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice.
Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this report, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law, to the resupply of services.
Please also read our Terms & Conditions and Financial Services Guide for further information.
On the date of publishing this report (referred to on the Kalkine website), employees and/or associates of Kalkine and its related entities do not hold interests in any of the securities or other financial products covered on the Kalkine website unless those persons comply with certain safeguards, procedures, and disclosures.
Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.